Mazzoni F

Department of Brain and Behavioural Sciences, University of Pavia

11 papers · ORCID

ArticleKetamine

Glutamatergic Resonance and Dopaminergic Stability: Intranasal Esketamine in Treatment-Resistant Depression with Comorbid ADHD and Autism Spectrum Disorder – A Case Report

Angeletti M, La Monica K, Casati V +9

Europe PMC2026
ArticleKetamine

Personality Disorders and Clinical Response to Intranasal Esketamine in Treatment-Resistant Depression: Trajectories, Modulations, and Psychopathological Reflections

Casati V, La Monica K, Angeletti M +11

Europe PMC2026
ArticleKetamine

Like Stepping Outside the Noise: Narrative Experiences of Esketamine-Induced Dissociation in Patients with Treatment-Resistant Depression

Versaci G, Olivola M, La Monica K +11

Europe PMC2026
ArticleKetamine

Suicidal ideation covaries with depressive severity during six-month real-world esketamine treatment in a cohort enriched for borderline personality disorder.

Martiadis V, Raffone F, Mazzoni F +6

Europe PMC2026
ArticleKetamine

Intranasal esketamine in treatment-resistant depression with and without comorbid borderline personality disorder: A multicenter real-world longitudinal study.

Mazzoni F, Raffone F, De Ciechi A +6

Europe PMC2026
ArticleKetamine

Esketamine in treatment-resistant depression with and without comorbid borderline personality disorder: A real-world longitudinal study of suicidal ideation and self-harm.

Raffone F, Mazzoni F, De Ciechi A +6

Europe PMC2026
ArticleKetamine

Personalizing esketamine treatment in TRD and TRBD: the role of mentalization, cognitive rigidity, psychache, and suicidality.

Olivola M, Mazzoni F, Tarantino B +12

Europe PMC2025
ArticleKetamine

Mentalization and Emotional-Cognitive Rigidity as predictors of esketamine's effects on Treatment-Resistant Depression: Findings from a prospective observational study.

Olivola M, Mazzoni F, Tarantino B +11

Europe PMC2026
ArticleKetamine

Depression and suicidal risk in autism spectrum disorder: efficacy of intranasal esketamine. Clinical experience from a public mental health service in Italy

Guffanti A, Mazzoni F, Silva A +4

Europe PMC2025
ArticleKetamine

“Improvements in Reflective Functioning in Patients with Treatment-Resistant Depression and Personality Disorder Treated with Esketamine”

Olivola M, Mazzoni F, Alessandro G +3

Europe PMC2025
ArticleKetamine

Esketamine for resistant depression in older people with cognitive impairment: a case report

Mazzoni F, Arienti V, Civardi S +6

Europe PMC2024